カテゴリ： MarketLine, アメリカ, 企業調査

Myriad Genetics, Inc.：企業の戦略・SWOT・財務分析

◆英語タイトル：Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4299
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：51
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Myriad Genetics, Inc. (Myriad or ‘the company’) is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. It operates a CLIA-certified laboratory facility in Salt Lake City, Utah to perform most of the molecular diagnostic tests; a CLIA-certified laboratory in South San Francisco, California; a single laboratory facility in Munich, Germany to perform the international molecular diagnostic tests; and a CLIA-certified laboratory facility in Austin, Texas. The company has operations in the US and Europe. The company is headquartered in Salt Lake City, Utah, the US.

Scope

- Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments
- Intelligence on Myriad Genetics, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Myriad Genetics, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Myriad Genetics, Inc.: Company Overview
Myriad Genetics, Inc.: Overview and Key Facts
Myriad Genetics, Inc.: Overview
Myriad Genetics, Inc.: Key Facts
Myriad Genetics, Inc.: Key Employees
Myriad Genetics, Inc.: Key Employee Biographies
Myriad Genetics, Inc.: Major Products and Services
Myriad Genetics, Inc.: Company History
Myriad Genetics, Inc.: Management Statement
Myriad Genetics, Inc.: Locations and Subsidiaries
Myriad Genetics, Inc.: Key Competitors
Myriad Genetics, Inc.: Company Analysis
Myriad Genetics, Inc.: Business Description
Myriad Genetics, Inc.: SWOT Analysis
Myriad Genetics, Inc.: SWOT Overview
Myriad Genetics, Inc.: Strengths
Myriad Genetics, Inc.: Weaknesses
Myriad Genetics, Inc.: Opportunities
Myriad Genetics, Inc.: Threats
Myriad Genetics, Inc.: Corporate Financial Deals Activity
Myriad Genetics, Inc.: Financial Deals Overview
Myriad Genetics, Inc.: Targets and Partners
Myriad Genetics, Inc.: Top Deals 2016 – 2020YTD*
Myriad Genetics, Inc.: Advisors
Myriad Genetics, Inc.: Top Legal Advisors
Myriad Genetics, Inc.: Top Financial Advisors
Myriad Genetics, Inc.: Mergers and Acquisitions
Myriad Genetics, Inc.: Capital Raising
Myriad Genetics, Inc.: Partnership
Myriad Genetics, Inc.: Recent Developments
Myriad Genetics, Inc.: News and Events Summary
Myriad Genetics, Inc.: Contracts
Myriad Genetics, Inc.: Corporate Governance
Myriad Genetics, Inc.: Financial Performance
Myriad Genetics, Inc.: Market Developments
Myriad Genetics, Inc.: Regulatory and Legal Events
Myriad Genetics, Inc.: Research & Development
Myriad Genetics, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Myriad Genetics, Inc.: Key Facts
Table 2: Myriad Genetics, Inc.: Key Employees
Table 3: Myriad Genetics, Inc.: Company History
Table 4: Myriad Genetics, Inc.: Locations and Subsidiaries
Table 5: Myriad Genetics, Inc.: Key Competitors
Table 6: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Myriad Genetics, Inc.: Targets and Partners
Table 10: Myriad Genetics, Inc.: Top Deals 2016 - 2020YTD*
Table 11: Myriad Genetics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Myriad Genetics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Myriad Genetics, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Myriad Genetics, Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 15: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 16: Myriad Genetics, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 17: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 18: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 19: Myriad Genetics, Inc.: News and Events Summary
Table 20: Myriad Genetics, Inc.: Contracts
Table 21: Myriad Genetics, Inc.: Corporate Governance
Table 22: Myriad Genetics, Inc.: Financial Performance
Table 23: Myriad Genetics, Inc.: Market Developments
Table 24: Myriad Genetics, Inc.: Regulatory and Legal Events
Table 25: Myriad Genetics, Inc.: Research & Development
Table 26: Myriad Genetics, Inc.: Strategy and Operations

★海外企業調査レポート[Myriad Genetics, Inc.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Boule Diagnostics AB (BOUL)-医療機器分野：企業M&A・提携分析
    Summary Boule Diagnostics AB (Boule) is a medical device company that develops, manufactures and markets blood counting systems. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. Its products include blood cell counter and instruments, reag …
  • Pharming Group NV (PHARM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Pharming Group NV (Pharming) is a specialty pharmaceutical company which develops nutritional products for the treatment of genetic diseases and unmet medical needs. The company’s flagship product, Ruconest (Rhucin in non-European territories) is a recombinant human C1 inhibitor approved for …
  • Ortho-Clinical Diagnostics Inc：企業のM&A・事業提携・投資動向
    Ortho-Clinical Diagnostics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ortho-Clinical Diagnostics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Abeona Therapeutics Inc (ABEO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associ …
  • TransAlta Corporation (TA)：電力：M&Aディール及び事業提携情報
    Summary TransAlta Corporation (TransAlta) is an electricity generation company. It owns, operates and develops a divergent fleet of electricity generation assets. It generates electricity from a contracted portfolio of assets using diverse sources such as coal, natural gas, hydro, wind and geotherma …
  • Williams-Sonoma, Inc.：企業の戦略・SWOT・財務情報
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Novita Healthcare Ltd (NHL)-製薬・医療分野：企業M&A・提携分析
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • HCA Healthcare Inc (HCA)：企業の財務・戦略的SWOT分析
    HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fox Corp (FOXA)：企業の財務・戦略的SWOT分析
    Fox Corp (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Seagate Technology Public Limited Company：企業のM&A・事業提携・投資動向
    Seagate Technology Public Limited Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Seagate Technology Public Limited Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • M1 Ltd (B2F)：企業の財務・戦略的SWOT分析
    M1 Ltd (B2F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Aslan Pharmaceuticals Pte Ltd (6497)：製薬・医療：M&Aディール及び事業提携情報
    Summary Aslan Pharmaceuticals Pte Ltd (Aslan), a subsidiary of Aslan Pharmaceuticals Ltd, is a biotechnology company that offers immuno-oncology agents and targeted therapies. The company’s pipeline products comprise varlitinib, ASLAN002, ASLAN003 and ASLAN004. Its ASLAN002 is a small molecule inhib …
  • Delphi Energy Corp (DEE)：企業の財務・戦略的SWOT分析
    Delphi Energy Corp (DEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mediobanca Banca di Credito Finanziario S.p.A.：企業の戦略・SWOT・財務分析
    Mediobanca Banca di Credito Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Mediobanca Banca di Credito Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Oneness Biotech Co Ltd (4743)：企業の財務・戦略的SWOT分析
    Summary Oneness Biotech Co Ltd (Oneness Biotech) is a bio pharmaceutical company that conducts research and development of drugs. The company provides products such as anti acne products. Its technologies comprise GAP cultivation platform, medicinal material identification, and separation and purifi …
  • JMC Projects (India) Ltd (JMCPROJECT)：企業の財務・戦略的SWOT分析
    JMC Projects (India) Ltd (JMCPROJECT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Fujitsu Limited：企業の戦略・SWOT・財務分析
    Fujitsu Limited - Strategy, SWOT and Corporate Finance Report Summary Fujitsu Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Funai Electric Co Ltd (6839)：企業の財務・戦略的SWOT分析
    Funai Electric Co Ltd (6839) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Babcock & Wilcox Enterprises Inc (BW)：企業の財務・戦略的SWOT分析
    Babcock & Wilcox Enterprises Inc (BW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Atos SE：企業の戦略・SWOT・財務情報
    Atos SE - Strategy, SWOT and Corporate Finance Report Summary Atos SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆